Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Jabs

Showing results (191-200 of 367) with videos related to

Pageof 37
Sort By:
Investigative Ophthalmology & Visual Science|May 1, 1987
Bullous pemphigoid autoantibodies are markers of corneal epithelial hemidesmosomesG J Anhalt, H D Jampel, H P Patel, et al.
Ophthalmology|September 8, 2007
Periocular triamcinolone and photodynamic therapy for subfoveal choroidal neovascularization in age-related macular degeneration, Marta M Gilson, Neil M Bressler, et al.
American Journal of Ophthalmology|October 29, 2021
Reply to Comment on: Classification Criteria for Behçet Disease UveitisAnnabelle A Okada, Alan G Palestine, Michal Kramer, et al.
Ophthalmology|July 13, 2014
Author reply: To PMID 24359625Russell W Read, Grace Levy-Clarke, Douglas A Jabs, et al.
Ophthalmology|December 24, 2013
Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disordersGrace Levy-Clarke, Douglas A Jabs, Russell W Read, et al.
Arthritis and Rheumatism|July 1, 1989
Characterization of the class I HLA 9.2-kb PVU II restriction fragment length polymorphism. Linkage to HLA-A and lack of disease associationJ M Ahearn, J J Calomiris, F M Wigley, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|April 1, 1986
Severe retinal vaso-occlusive disease in systemic lupus erythematousD A Jabs, S L Fine, M C Hochberg, et al.
The Journal of Infectious Diseases|February 25, 2003
Mutations conferring foscarnet resistance in a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitisAdriana Weinberg, Douglas A Jabs, Sunwen Chou, et al.
Ophthalmology|August 3, 2005
Mycophenolate mofetil therapy for inflammatory eye diseaseJennifer E Thorne, Douglas A Jabs, Faqir A Qazi, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 26, 2010
Mitochondrial haplogroups are associated with risk of neuroretinal disorder in HIV-positive patientsSher L Hendrickson, Douglas A Jabs, Mark Van Natta, et al.
Pageof 37

Showing results (191-200 of 367) with videos related to

Sort By:
Pageof 37
Investigative Ophthalmology & Visual Science|May 1, 1987
Bullous pemphigoid autoantibodies are markers of corneal epithelial hemidesmosomesG J Anhalt, H D Jampel, H P Patel, et al.
Ophthalmology|September 8, 2007
Periocular triamcinolone and photodynamic therapy for subfoveal choroidal neovascularization in age-related macular degeneration, Marta M Gilson, Neil M Bressler, et al.
American Journal of Ophthalmology|October 29, 2021
Reply to Comment on: Classification Criteria for Behçet Disease UveitisAnnabelle A Okada, Alan G Palestine, Michal Kramer, et al.
Ophthalmology|July 13, 2014
Author reply: To PMID 24359625Russell W Read, Grace Levy-Clarke, Douglas A Jabs, et al.
Ophthalmology|December 24, 2013
Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disordersGrace Levy-Clarke, Douglas A Jabs, Russell W Read, et al.
Arthritis and Rheumatism|July 1, 1989
Characterization of the class I HLA 9.2-kb PVU II restriction fragment length polymorphism. Linkage to HLA-A and lack of disease associationJ M Ahearn, J J Calomiris, F M Wigley, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|April 1, 1986
Severe retinal vaso-occlusive disease in systemic lupus erythematousD A Jabs, S L Fine, M C Hochberg, et al.
The Journal of Infectious Diseases|February 25, 2003
Mutations conferring foscarnet resistance in a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitisAdriana Weinberg, Douglas A Jabs, Sunwen Chou, et al.
Ophthalmology|August 3, 2005
Mycophenolate mofetil therapy for inflammatory eye diseaseJennifer E Thorne, Douglas A Jabs, Faqir A Qazi, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 26, 2010
Mitochondrial haplogroups are associated with risk of neuroretinal disorder in HIV-positive patientsSher L Hendrickson, Douglas A Jabs, Mark Van Natta, et al.
Pageof 37